1. Home
  2. GCT vs PVLA Comparison

GCT vs PVLA Comparison

Compare GCT & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GCT

GigaCloud Technology Inc

HOLD

Current Price

$39.33

Market Cap

1.7B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$121.26

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
PVLA
Founded
2019
2015
Country
United States
United States
Employees
N/A
14
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GCT
PVLA
Price
$39.33
$121.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$33.00
$171.87
AVG Volume (30 Days)
748.0K
174.4K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
1.04
N/A
Revenue
$1,161,042,000.00
N/A
Revenue This Year
$14.43
N/A
Revenue Next Year
$6.78
$104,350.18
P/E Ratio
$38.91
N/A
Revenue Growth
64.96
N/A
52 Week Low
$16.25
$20.20
52 Week High
$51.82
$151.18

Technical Indicators

Market Signals
Indicator
GCT
PVLA
Relative Strength Index (RSI) 39.07 47.24
Support Level $38.42 $108.99
Resistance Level $44.01 $135.23
Average True Range (ATR) 2.77 8.08
MACD -0.79 -1.20
Stochastic Oscillator 1.38 37.13

Price Performance

Historical Comparison
GCT
PVLA

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: